No abstract available
MeSH terms
-
Abnormalities, Drug-Induced / prevention & control
-
Administration, Ophthalmic
-
Administration, Oral
-
Adrenergic beta-Antagonists / administration & dosage
-
Adrenergic beta-Antagonists / adverse effects
-
Adrenergic beta-Antagonists / therapeutic use*
-
Animals
-
Brimonidine Tartrate
-
Carbonic Anhydrase Inhibitors / administration & dosage
-
Carbonic Anhydrase Inhibitors / adverse effects
-
Carbonic Anhydrase Inhibitors / therapeutic use*
-
Contraindications
-
Female
-
Fetus / drug effects
-
Gels
-
Glaucoma / drug therapy*
-
Glaucoma / physiopathology
-
Glaucoma / surgery
-
Humans
-
Hypotension / chemically induced
-
Intraocular Pressure
-
Lactation*
-
Obstetric Labor, Premature / prevention & control
-
Ophthalmic Solutions
-
Pregnancy
-
Pregnancy Complications / drug therapy*
-
Pregnancy Complications / physiopathology
-
Pregnancy Complications / surgery
-
Prostaglandins / therapeutic use
-
Quinoxalines / adverse effects
-
Quinoxalines / therapeutic use
-
Timolol / administration & dosage
-
Timolol / adverse effects
-
Timolol / therapeutic use
Substances
-
Adrenergic beta-Antagonists
-
Carbonic Anhydrase Inhibitors
-
Gels
-
Ophthalmic Solutions
-
Prostaglandins
-
Quinoxalines
-
Brimonidine Tartrate
-
Timolol